Abstract
Background: Caregivers of persons with Alzheimer’s Disease (AD) often experience feelings of lack of support and information from specialists when operating in real scenarios, inclusive of old-age psychiatric wards, care homes, community, and patient’s home.
Objective: AD caregivers can provide narrative about what issues need to be addressed in Ecological Momentary Assessment (EMA) to capture real-time and real-scenario needs in AD caregiving, and Ecological Momentary Interventions (EMI) as online e-learning to assist in areas of concerns.
Method: Twelve focus group discussions took place with AD caregivers for a total of 62 people interviewed. Once major themes in surveys and learning were identified by using discourse analysis, AD caregivers expressed the likelihood that these themes (where 0 meant “nil” and 1 meant “completely”) would address their focal needs in caregiving and topics in learning. Z scores for proportions and Cohen’s d effect size were calculated for each item reporting the averaged scores.
Results: AD caregivers indicated that the major areas of concern that could benefit from an EMA/EMI online platform were: support (d=3.08), collaboration (d=1.85), medication review (d=1.21), dealing with grief and mourning, and time (d=0.97). Moreover, they identified personal resources available to provide help to colleagues: support (d=1.34), information (d=0.97), collaboration (d=2.06), hospital admission (d=3.08), and hospital discharge (d=5.50).
Conclusion: Focus groups and narratives can be the initial stage in creating a dedicated AD app supporting EMA/EMI in AD care.
Keywords: Alzheimer`s disease, caregivers, e-learning, educational apps, ecological momentary assessment, ecological momentary intervention.
Current Alzheimer Research
Title:Ecological Momentary Assessments and Interventions in Alzheimer’s Caregiving
Volume: 15 Issue: 11
Author(s): Carlo Lazzari*
Affiliation:
- International Centre for Healthcare and Medical Education, King`s Wood Centre, Colchester CO45JY,United Kingdom
Keywords: Alzheimer`s disease, caregivers, e-learning, educational apps, ecological momentary assessment, ecological momentary intervention.
Abstract: Background: Caregivers of persons with Alzheimer’s Disease (AD) often experience feelings of lack of support and information from specialists when operating in real scenarios, inclusive of old-age psychiatric wards, care homes, community, and patient’s home.
Objective: AD caregivers can provide narrative about what issues need to be addressed in Ecological Momentary Assessment (EMA) to capture real-time and real-scenario needs in AD caregiving, and Ecological Momentary Interventions (EMI) as online e-learning to assist in areas of concerns.
Method: Twelve focus group discussions took place with AD caregivers for a total of 62 people interviewed. Once major themes in surveys and learning were identified by using discourse analysis, AD caregivers expressed the likelihood that these themes (where 0 meant “nil” and 1 meant “completely”) would address their focal needs in caregiving and topics in learning. Z scores for proportions and Cohen’s d effect size were calculated for each item reporting the averaged scores.
Results: AD caregivers indicated that the major areas of concern that could benefit from an EMA/EMI online platform were: support (d=3.08), collaboration (d=1.85), medication review (d=1.21), dealing with grief and mourning, and time (d=0.97). Moreover, they identified personal resources available to provide help to colleagues: support (d=1.34), information (d=0.97), collaboration (d=2.06), hospital admission (d=3.08), and hospital discharge (d=5.50).
Conclusion: Focus groups and narratives can be the initial stage in creating a dedicated AD app supporting EMA/EMI in AD care.
Export Options
About this article
Cite this article as:
Lazzari Carlo *, Ecological Momentary Assessments and Interventions in Alzheimer’s Caregiving, Current Alzheimer Research 2018; 15 (11) . https://dx.doi.org/10.2174/1567205015666180702111523
DOI https://dx.doi.org/10.2174/1567205015666180702111523 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
Call for Papers in Thematic Issues
New Advances in the Prevention, Diagnosis, Treatment, and Rehabilitation of Alzheimer's Disease
Aims and Scope: Introduction: Alzheimer's disease (AD) poses a significant global health challenge, with an increasing prevalence that demands concerted efforts to advance our understanding and strategies for prevention, diagnosis, treatment, and rehabilitation. This thematic issue aims to bring together cutting-edge research and innovative approaches from multidisciplinary perspectives to address ...read more
Current updates on the Role of Neuroinflammation in Neurodegenerative Disorders
Neuroinflammation is an invariable hallmark of chronic and acute neurodegenerative disorders and has long been considered a potential drug target for Alzheimer?s disease (AD) and dementia. Significant evidence of inflammatory processes as a feature of AD is provided by the presence of inflammatory markers in plasma, CSF and postmortem brain ...read more
Deep Learning for Advancing Alzheimer's Disease Research
Alzheimer's disease (AD) poses a significant global health challenge, with an increasing number of individuals affected yearly. Deep learning, a subfield of artificial intelligence, has shown immense potential in various domains, including healthcare. This thematic issue of Current Alzheimer Research explores the application of deep learning techniques in advancing our ...read more
Diagnostic and therapeutic biomarkers of dementia
Dementia affects 18 million people worldwide. Dementia is a syndrome of symptoms caused by brain disease, usually chronic or progressive, clinically characterized by multiple impairments of higher cortical functions such as memory, thinking, orientation, and learning. In addition, in the course of dementia, cognitive deficits are observed, which often hinder ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Novel Therapies for Asthma - Advances and Problems
Current Pharmaceutical Design The Menstrual Cycle and Drug Metabolism
Current Drug Metabolism In Transitional Space: A Whirlwind Tour of the DSM-5
Adolescent Psychiatry Patent Selections
Recent Patents on Regenerative Medicine Abnormal Head Posture due to Ocular Problems- A Review
Current Pediatric Reviews Update on Autoimmune Diseases Pathogenesis
Current Pharmaceutical Design Neurobiological Effects of Hyperforin and its Potential in Alzheimers Disease Therapy
Current Medicinal Chemistry Low-Dose Radiation Stimulates Wnt/β-Catenin Signaling, Neural Stem Cell Proliferation and Neurogenesis of the Mouse Hippocampus in vitro and in vivo
Current Alzheimer Research Role of Antioxidants in Redox Regulation of Diabetic Cardiovascular Complications
Current Pharmaceutical Biotechnology Angiogenesis Inhibition in the Treatment of Prostate Cancer
Anti-Cancer Agents in Medicinal Chemistry Amyloid Precursor Protein Processing in Vivo - Insights from a Chemically- Induced Constitutive Overactivation of Protein Kinase C in Guinea Pig Brain
Current Medicinal Chemistry Targeting Interleukin-1β for Pain
CNS & Neurological Disorders - Drug Targets Obesity: An Emerging Importance of Progenitors
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Naphthalene Toxicity in Clinical Practice
Current Drug Metabolism The Challenge of Antiretroviral-Drug-Resistant HIV: Is There Any Possible Clinical Advantage?
Current HIV Research Vascular Reactions of Iodinated X-Ray Contrast Media: Mechanisms and Possible Therapeutic Interventions
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Editorial (Thematic Issue: Targeting Phosphodiesterases (PDEs) for Treatment of CNS Diseases)
Current Pharmaceutical Design Strategies to Overcome or Circumvent P-Glycoprotein Mediated Multidrug Resistance
Current Medicinal Chemistry Editorial: [Hot Topics: A New Horizon of Herbal Medicines in Anorexia-Cachexia Syndrome]
Current Pharmaceutical Design Pharmacological Management of Acutely Agitated Schizophrenic Patients
Current Pharmaceutical Design